Study of Effectiveness of IMC-A12 Antibody Combined With Hormone Therapy Prior to Surgery to Treat Prostate Cancer

NCT00769795 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: IMC-A12
DRUG: Bicalutamide
DRUG: Goserelin

Sponsor

University of Washington